CCCC - Financial Reports List - C4 Therapeutics, Inc. - IntrinsicAlpha

C4 Therapeutics, Inc. CCCC

Healthcare - Biotechnology - NASDAQ - US

$ 1.4

12 %

$ 99.4 M

Market Cap

-0.92

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2024-12-31	58.75%	0.52%	-0.75%
Annual Report	FY	10-K	2024-12-31	71.44%	20.51%	13.97%
Quarterly Report	Q2	8-K	2024-09-30	38.75%	8.77%	-1.57%
Quarterly Report	Q1	8-K	2024-06-30	350.68%	50.68%	42.92%
Quarterly Report	Q4	8-K	2024-03-31	-19.15%	16.43%	11.07%
Quarterly Report	Q3	8-K	2023-12-31	14.26%	3.67%	2.26%
Annual Report	FY	10-K	2023-12-31	-33.25%	-4.74%	-7.33%
Quarterly Report	Q2	8-K	2023-09-30	63.93%	13.97%	14.41%
Quarterly Report	Q1	8-K	2023-06-30	-80.74%	-30.91%	-37.19%
Quarterly Report	Q4	8-K	2023-03-31	-50.89%	-6.49%	-15.49%

1